Folate Autoantibodies & ASD Identification in Early Childhood - H. Huberman MD, SUNY @Sychrony2021

Harris Huberman, MD, is a developmental pediatrician and the director of the SUNY Downstate Division of Child Development. He was the Medical Director of the NYC Infant Child Health Assessment Program - NYC’s Early Intervention Child Find program and has been the PI of several NIH and MCHB-funded studies of interventions to improve early child development. Currently he is the PI on two clinical trials to treat young children with ASD with leucovorin in collaboration with Phoenix Children’s Hospital, and is the PD of the newly formed Brooklyn Leadership Education in Neurodisabilities (LEND) program funded by MCHB. Dr. Huberman’s areas of interest include: autism, public health and its intersection with child development, preventive parenting programs to improve developmental outcomes for children living in poverty, international health.   
 
Dr. Huberman currently directs the Behavior and Development rotation for Downstate’s pediatric residents and with his team runs a Child Development clinic which is heavily focused on identifying and caring for children on the Autism Spectrum. 

🎥 This talk was part of Synchrony 2021 Online Symposium - 'From Bench to Biopharma', organised by the The BRAIN Foundation in partnership with UC Davis MIND Institute and CalTech.

🎥 For more Synchrony 2021 talks and highlights:
   • Synchrony Symposium 2021 - From Bench...  


🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠

Synchrony https://synchronysymposium.com/ is the first and only international symposium on translational research in #autism, that brings together academia, #biotech, pharmaceutical companies and #venture partners from around the world with the mission to improve health and quality of life of people with #autismspectrumdisorder.

🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠

The BRAIN Foundation https://brainfoundation.org/ is a 501c(3) non-profit. The founders of BRAIN envision a world where every child and adult on the autism spectrum is healthy, participates fully in education and employment, and has a better quality of life. It aims to catalyze research that results in evidence-based interventions for the disabilities associated with autism, and also results in better medical standard of care.

To accomplish this, it funds impactful research through #philanthropy and our network of partners in the venture, corporate, and grassroots community.